These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34916444)

  • 21. Adjuvant therapy with antidepressants for the management of inflammatory bowel disease.
    Mikocka-Walus A; Prady SL; Pollok J; Esterman AJ; Gordon AL; Knowles S; Andrews JM
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012680. PubMed ID: 30977111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lycium barbarum (goji) juice improves in vivo antioxidant biomarkers in serum of healthy adults.
    Amagase H; Sun B; Borek C
    Nutr Res; 2009 Jan; 29(1):19-25. PubMed ID: 19185773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.
    Davis AK; Barrett FS; May DG; Cosimano MP; Sepeda ND; Johnson MW; Finan PH; Griffiths RR
    JAMA Psychiatry; 2021 May; 78(5):481-489. PubMed ID: 33146667
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Cui F; Shi CL; Zhou XJ; Wen W; Gao XP; Wang LY; He B; Yin M; Zhao JQ
    J Med Food; 2020 Jul; 23(7):699-710. PubMed ID: 32392444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detailed course of depressive symptoms and risk for developing depression in late adolescents with subthreshold depression: a cohort study.
    Jinnin R; Okamoto Y; Takagaki K; Nishiyama Y; Yamamura T; Okamoto Y; Miyake Y; Takebayashi Y; Tanaka K; Sugiura Y; Shimoda H; Kawakami N; Furukawa TA; Yamawaki S
    Neuropsychiatr Dis Treat; 2017; 13():25-33. PubMed ID: 28053534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving the activity of Lycium barbarum polysaccharide on sub-health mice.
    Zhao R; Cai Y; Shao X; Ma B
    Food Funct; 2015 Jun; 6(6):2033-40. PubMed ID: 26021745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of
    Shayesteh M; Vaez-Mahdavi MR; Shams J; Kamalinejad M; Faghihzadeh S; Gholami-Fesharaki M; Gharebaghi R; Heidary F
    J Altern Complement Med; 2020 May; 26(5):398-408. PubMed ID: 32073874
    [No Abstract]   [Full Text] [Related]  

  • 28. Effectiveness of attachment-based family therapy compared to treatment as usual for depressed adolescents in community mental health clinics.
    Waraan L; Rognli EW; Czajkowski NO; Aalberg M; Mehlum L
    Child Adolesc Psychiatry Ment Health; 2021 Feb; 15(1):8. PubMed ID: 33579332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effectiveness of Tai Chi on the depressive symptom of young adults with subthreshold depression: a study protocol for a randomized controlled trial.
    Xie X; Song J; Zhu J; Han M; He Y; Huang J; Tao J; Wu J
    Trials; 2021 Jan; 22(1):106. PubMed ID: 33516240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of light therapy for a college student sample with non-seasonal subthreshold depression: An RCT study.
    Jiang L; Zhang S; Wang Y; So KF; Ren C; Tao Q
    J Affect Disord; 2020 Dec; 277():443-449. PubMed ID: 32871530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of major depressive disorder using botulinum toxin A: a 24-week randomized, double-blind, placebo-controlled study.
    Magid M; Reichenberg JS; Poth PE; Robertson HT; LaViolette AK; Kruger TH; Wollmer MA
    J Clin Psychiatry; 2014 Aug; 75(8):837-44. PubMed ID: 24910934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychological and/or educational interventions for the prevention of depression in children and adolescents.
    Merry S; McDowell H; Hetrick S; Bir J; Muller N
    Cochrane Database Syst Rev; 2004; (1):CD003380. PubMed ID: 14974014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial.
    Su KP; Huang SY; Chiu TH; Huang KC; Huang CL; Chang HC; Pariante CM
    J Clin Psychiatry; 2008 Apr; 69(4):644-51. PubMed ID: 18370571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of comorbid subthreshold depressive symptoms on cancer-related fatigue and complications in adults with leukemia.
    Liu YX; Wang J
    World J Psychiatry; 2024 Jul; 14(7):1009-1016. PubMed ID: 39050202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial.
    Lecrubier Y; Clerc G; Didi R; Kieser M
    Am J Psychiatry; 2002 Aug; 159(8):1361-6. PubMed ID: 12153829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of St John's wort in major depression: a randomized controlled trial.
    Shelton RC; Keller MB; Gelenberg A; Dunner DL; Hirschfeld R; Thase ME; Russell J; Lydiard RB; Crits-Cristoph P; Gallop R; Todd L; Hellerstein D; Goodnick P; Keitner G; Stahl SM; Halbreich U
    JAMA; 2001 Apr; 285(15):1978-86. PubMed ID: 11308434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quetiapine monotherapy in acute phase for major depressive disorder: a meta-analysis of randomized, placebo-controlled trials.
    Maneeton N; Maneeton B; Srisurapanont M; Martin SD
    BMC Psychiatry; 2012 Sep; 12():160. PubMed ID: 23017200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of quetiapine XR vs. placebo as concomitant treatment to mood stabilizers in the control of subthreshold symptoms of bipolar disorder: Results from a pilot, randomized controlled trial.
    Garriga M; Solé E; González-Pinto A; Selva-Vera G; Arranz B; Amann BL; Saiz-Ruiz J; Pérez-Blanco J; Vieta E
    Eur Neuropsychopharmacol; 2017 Oct; 27(10):959-969. PubMed ID: 28882405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.